Omeprazole treatment of severe peptic disease associated with antral G cell hyperfunction and hyperpepsinogenemia I in an infant
Authors:
- R. FloccaRFR. Flocca
- L. VillaniLVL. Villani
- G. LicardiGLG. Licardi
- M.S. ScottaMSM.S. Scotta
- E. SolciaESE. Solcia
- 31 December 1990
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 117 (6) , 989-993
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Gastric Argyrophil Carcinoidosis in Patients with Zollinger-Ellison Syndrome Due to Type 1 Multiple Endocrine NeoplasiaAmerican Journal of Surgical Pathology, 1990
- GASTRIC CARCINOID TUMOURS IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME ON LONG-TERM OMEPRAZOLEThe Lancet, 1989
- Long-Term Omeprazole Treatment in Man: Effects on Gastric Endocrine Cell PopulationsDigestion, 1988
- Plasma gastrin and gastric enterochromaffinlike cell activation and proliferationGastroenterology, 1986
- Enterochromaffin-Like Cell Carcinoids of Gastric Mucosa in Rats after Life-Long Inhibition of Gastric SecretionDigestion, 1986
- Omeprazole in Zollinger–Ellison SyndromeNew England Journal of Medicine, 1984
- Basal and pentagastrin-stimulated gastric acid secretory rates in normal children and in those with peptic ulcer diseaseThe Journal of Pediatrics, 1983
- Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.Gut, 1983
- Pseudo-Zollinger-Ellison SyndromeAnnals of Surgery, 1981
- Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPaseNature, 1981